Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocytes | 4 | 2025 | 245 | 1.050 |
Why?
|
| Genes, Essential | 1 | 2025 | 43 | 0.910 |
Why?
|
| Gene Targeting | 1 | 2025 | 185 | 0.870 |
Why?
|
| Atherosclerosis | 3 | 2022 | 1002 | 0.810 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2020 | 33 | 0.690 |
Why?
|
| Terpenes | 1 | 2020 | 30 | 0.690 |
Why?
|
| Liver | 5 | 2025 | 1880 | 0.680 |
Why?
|
| Dependovirus | 4 | 2025 | 151 | 0.680 |
Why?
|
| Apyrase | 2 | 2017 | 20 | 0.670 |
Why?
|
| Hyperlipidemias | 1 | 2022 | 198 | 0.660 |
Why?
|
| Hypercholesterolemia | 2 | 2022 | 236 | 0.650 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 130 | 0.650 |
Why?
|
| Gene Editing | 5 | 2025 | 213 | 0.650 |
Why?
|
| Antigens, CD | 2 | 2017 | 452 | 0.570 |
Why?
|
| Genetic Vectors | 5 | 2025 | 970 | 0.550 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 139 | 0.530 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 204 | 0.510 |
Why?
|
| Dyslipidemias | 1 | 2019 | 245 | 0.490 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 387 | 0.490 |
Why?
|
| Lipids | 1 | 2019 | 566 | 0.470 |
Why?
|
| Genetic Therapy | 2 | 2025 | 737 | 0.470 |
Why?
|
| CRISPR-Cas Systems | 3 | 2022 | 296 | 0.420 |
Why?
|
| Transgenes | 4 | 2025 | 346 | 0.330 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2020 | 73 | 0.290 |
Why?
|
| Mice | 10 | 2025 | 19030 | 0.290 |
Why?
|
| Animals | 12 | 2025 | 36524 | 0.260 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 2092 | 0.250 |
Why?
|
| Cholesterol | 2 | 2020 | 574 | 0.240 |
Why?
|
| Hydrolases | 1 | 2025 | 61 | 0.230 |
Why?
|
| Viral Tropism | 1 | 2025 | 53 | 0.220 |
Why?
|
| Fabry Disease | 1 | 2022 | 18 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 3853 | 0.190 |
Why?
|
| DNA Repair | 1 | 2025 | 632 | 0.180 |
Why?
|
| Mevalonic Acid | 1 | 2020 | 21 | 0.170 |
Why?
|
| Prostate | 1 | 2023 | 448 | 0.170 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 278 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4867 | 0.160 |
Why?
|
| Heat-Shock Proteins | 1 | 2020 | 204 | 0.150 |
Why?
|
| RNAi Therapeutics | 1 | 2019 | 17 | 0.150 |
Why?
|
| Cell Lineage | 1 | 2020 | 370 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 189 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 89 | 0.150 |
Why?
|
| Receptors, LDL | 1 | 2018 | 102 | 0.140 |
Why?
|
| Gene Expression | 3 | 2020 | 1621 | 0.140 |
Why?
|
| Regeneration | 1 | 2020 | 231 | 0.140 |
Why?
|
| Gene Deletion | 1 | 2020 | 810 | 0.140 |
Why?
|
| Platelet Activation | 1 | 2017 | 71 | 0.130 |
Why?
|
| Necrosis | 1 | 2017 | 221 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 719 | 0.130 |
Why?
|
| Biological Transport | 1 | 2017 | 371 | 0.130 |
Why?
|
| Myocarditis | 1 | 2017 | 137 | 0.130 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 21 | 0.120 |
Why?
|
| Apoptosis | 2 | 2020 | 1940 | 0.120 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 32 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2017 | 249 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2020 | 4006 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 1624 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2557 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2195 | 0.100 |
Why?
|
| Cell Movement | 1 | 2017 | 917 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 703 | 0.100 |
Why?
|
| Macrophages | 1 | 2017 | 703 | 0.100 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1870 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2015 | 922 | 0.090 |
Why?
|
| Phenotype | 2 | 2020 | 4554 | 0.090 |
Why?
|
| Humans | 10 | 2025 | 134032 | 0.080 |
Why?
|
| Gene Order | 2 | 2020 | 82 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4801 | 0.070 |
Why?
|
| Male | 6 | 2025 | 66022 | 0.060 |
Why?
|
| Serogroup | 1 | 2025 | 63 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2022 | 2299 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2025 | 402 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2025 | 296 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2019 | 13050 | 0.050 |
Why?
|
| Prostatectomy | 1 | 2023 | 357 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2022 | 114 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2022 | 307 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 63 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2020 | 54 | 0.040 |
Why?
|
| SOX9 Transcription Factor | 1 | 2020 | 87 | 0.040 |
Why?
|
| Radiography | 1 | 2021 | 825 | 0.040 |
Why?
|
| Peptides | 1 | 2023 | 861 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 342 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 215 | 0.040 |
Why?
|
| Bile Duct Neoplasms | 1 | 2020 | 121 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 121 | 0.040 |
Why?
|
| Immunization | 1 | 2020 | 315 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2020 | 199 | 0.040 |
Why?
|
| Proprotein Convertase 9 | 1 | 2018 | 82 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 718 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 500 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 912 | 0.030 |
Why?
|
| Heart | 1 | 2022 | 749 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2017 | 109 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 3043 | 0.030 |
Why?
|
| Rats | 1 | 2023 | 3890 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 1430 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1854 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 97 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 611 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2018 | 610 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2017 | 535 | 0.030 |
Why?
|
| Stem Cells | 1 | 2020 | 753 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2017 | 485 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1535 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 390 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2536 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 649 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 1191 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 2041 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2444 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3432 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 3181 | 0.020 |
Why?
|
| Female | 3 | 2025 | 71818 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 5206 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 2174 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 17507 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 29393 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 31958 | 0.010 |
Why?
|